Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesSep 18, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 17, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 17, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 7, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 6, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 30, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 29, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 28, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 22, 2018View HTMLDownload DOCDownload PDF
S-8 POSPost-effective amendment to an S-8 filingAug 22, 2018View HTMLDownload DOCDownload PDFDownload XLS
S-8 POSPost-effective amendment to an S-8 filingAug 22, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 9, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 9, 2018View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 3, 2018View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventAug 2, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 25, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 29, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 26, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 26, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 18, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 18, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 14, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJun 14, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 13, 2018View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-125      126-146

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information